Cargando…
Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients
OBJECTIVES: To clarify the contemporary clinical outcome of stage I seminoma and to provide information on treatment options to patients. METHODS: A retrospective analysis of 425 patients who underwent orchiectomy for stage I seminoma between 1985 and 2006 at 25 hospitals in Japan. Relapse-free surv...
Autores principales: | Kamba, Tomomi, Kamoto, Toshiyuki, Okubo, Kazutoshi, Teramukai, Satoshi, Kakehi, Yoshiyuki, Matsuda, Tadashi, Ogawa, Osamu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Asia
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017741/ https://www.ncbi.nlm.nih.gov/pubmed/20955354 http://dx.doi.org/10.1111/j.1442-2042.2010.02645.x |
Ejemplares similares
-
Allelic Imbalances on Chromosome 20 in Human Transitional Cell Carcinoma
por: Higashi, Shin, et al.
Publicado: (2000) -
Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy
por: Kobayashi, Kazuhiro, et al.
Publicado: (2013) -
Partial orchiectomy vs. radical orchiectomy for pediatric testis tumors
por: Woo, Lynn L., et al.
Publicado: (2020) -
Stage IIA and IIB testicular seminoma treated post-orchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients
por: Ahmed, Kamran A., et al.
Publicado: (2015) -
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study
por: Sugimoto, Mikio, et al.
Publicado: (2022)